World News Now: Affordable Medical Insurance >
   
      
Home | Login | Feeling Stressed? | FAQ's | Contact us    
Studies on HIV
Heterosexual HIV cases increasing
HIV teens 'taking more sex risks'
Tough challenges remain in Aids fight
HIV blips 'no cause for concern'
HIV parents 'limit child kisses'
Drug-resistant HIV strain found
Gene clue to HIV origin in humans
How safe are the drugs we take?
HIV can be flushed out of hiding
Key HIV-fighting genes identified
Women bearing the brunt of HIV
Heart drugs 'may slow down HIV'
Chemicals may damage male babies
Toxins Pass Disease To Next Generation
Register for News
Links

Drug-resistant HIV strain found

Health officials in New York say they have found a new strain of highly drug-resistant HIV in a city resident.

New York health officials are looking for other cases of the strain

The resident, a man in his mid-40s, is thought to have developed Aids much faster than usual after infection.

The strain - known as 3-DCR HIV - has not been detected anywhere else in the world and is "difficult or impossible to treat", according to health experts.

The discovery prompted renewed warnings from city health officials for people to practise safe sex.

New York health workers are now hunting other possible cases of the strain.

Experts say drug resistance is increasingly common among people with HIV, but not when accompanied by such a quick progression to Aids.

'Wake-up call'

What's unique about this is the combination of multiple drug resistance and a rapid course - to folks in the public health community, that is a particularly dangerous combination.

Ronald Valdiserri, Centers for Disease Control and Prevention

Officials said he frequently used the drug crystal methamphetamine, a stimulant taken to reduce sexual inhibitions.

The man - who has not been named - is thought have been infected quite recently, and developed Aids between two and 20 months after infection. Progression to Aids usually takes about 10 years.

The strain was found to be resistant to three out of the four commonest anti-retroviral drugs.

Ronald Valdiserri, director of the HIV/Aids programme at the US Centers for Disease Control, no similar case had been found anywhere in the world.

"What's unique about this is the combination of multiple drug resistance and a rapid course," he told the New York Times newspaper. "To folks in the public health community, that is a particularly dangerous combination."

However, some Aids specialists outside New York have cast doubt on the alarm, saying that the man's immune system may already have been compromised, the newspaper said.


Source: BBC News

Site Map American Healthcare Foundation : HomePrivacy & Terms

An Educational Program of The American Healthcare Foundation
© 2004, 2005 The American Healthcare Foundation

Disclaimer: This site is provided for general information only, and is not a substitute for the medical advice of your own doctor or other health care professional. This site is not responsible or liable for any diagnosis made by a user based on the content of this website. This site is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of such sites. Always consult your own doctor.


support